Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease

Journal of the American Society of Nephrology

Volumn 13, Issue 2, 2002, Pages 490-496

  Zoccali, Carmine ^a   Benedetto, Francesco Antonio ^a   Maas, Renke ^a   Mallamaci, Francesca ^a   Tripepi, Giovanni ^a   Malatino, Lorenzo Salvatore ^a   Böger, Rainer ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHRONIC KIDNEY FAILURE; ENDOTHELIUM LESION; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0036156916     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases
2. Asymmetric dimethylarginine: A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia
3. Dietary L-arginine slows the progression of atherosclerosis in cholesterol-fed rabbits-comparison with lovastatin
4. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
5. Endogenous nitric oxide synthase inhibitor. A novel marker of atherosclerosis
6. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease
7. Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure
8. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure
9. Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients
10. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease
11. Asymmetric Dimethylarginine (ADMA): An endogenous inhibitor of nitric oxide synthase predicts mortality in end-stage renal disease (ESRD)
12. Hemodialysis hypotension: Interaction of inhibitors, iNOS, and the interdialytic period
13. Total nitric oxide production is low in patients with chronic renal failure
14. C-reactive protein and chronic chlamydia pneumoniae infection long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis
15. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive Protein the missing link?
16. Inflammation is associated with carotid atherosclerosis in dialysis patients
17. Ultrasound in clinical trials in atherosclerosis
18. The renin-angiotensin-aldosterone system and carotid artery disease in mild-to-moderate primary hypertension
19. Noninvasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurements of arterial wall thickness and plaque size
20. High performance liquid chromatographic method for measuring total plasma homocysteine levels
21. Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients
22. The Verapamil in Hypertension and Atherosclerosis Study (VHAS): Results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness
23. Predictions for future growth of ESRD prevalence
24. Prognostic impact of ultrasonography measurement of carotid intima media thickness in dialysis patients
25. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) study
26. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
27. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure
28. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite
29. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates
30. Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerostic disease
31. Altered flow-dependent vasodilatation of conduit arteries in maintenance hemodialysis
32. Physiology and biochemistry of endothelial function in children with chronic renal failure
33. Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction
34. Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilation in normotensive patients on chronic hemodialysis